杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2011/10/25 | 1,450 | 1,454 | 1,419 | 1,425 | -40 | -2.7% | 225,000 |
| 2011/10/24 | 1,477 | 1,480 | 1,464 | 1,465 | -17 | -1.1% | 108,000 |
| 2011/10/21 | 1,492 | 1,492 | 1,473 | 1,482 | -14 | -0.9% | 62,000 |
| 2011/10/20 | 1,480 | 1,512 | 1,476 | 1,496 | +20 | +1.4% | 212,000 |
| 2011/10/19 | 1,473 | 1,484 | 1,469 | 1,476 | +21 | +1.4% | 76,000 |
| 2011/10/18 | 1,447 | 1,462 | 1,447 | 1,455 | -10 | -0.7% | 41,000 |
| 2011/10/17 | 1,478 | 1,487 | 1,464 | 1,465 | +13 | +0.9% | 74,000 |
| 2011/10/14 | 1,446 | 1,460 | 1,439 | 1,452 | -10 | -0.7% | 162,000 |
| 2011/10/13 | 1,477 | 1,482 | 1,461 | 1,462 | -16 | -1.1% | 150,000 |
| 2011/10/12 | 1,481 | 1,501 | 1,464 | 1,478 | -22 | -1.5% | 175,000 |
| 2011/10/11 | 1,503 | 1,537 | 1,480 | 1,500 | -2 | -0.1% | 215,000 |
| 2011/10/07 | 1,526 | 1,542 | 1,501 | 1,502 | -12 | -0.8% | 167,000 |
| 2011/10/06 | 1,513 | 1,521 | 1,497 | 1,514 | -7 | -0.5% | 90,000 |
| 2011/10/05 | 1,577 | 1,577 | 1,508 | 1,521 | -68 | -4.3% | 258,000 |
| 2011/10/04 | 1,604 | 1,618 | 1,586 | 1,589 | -34 | -2.1% | 160,000 |
| 2011/10/03 | 1,606 | 1,629 | 1,587 | 1,623 | +5 | +0.3% | 126,000 |
| 2011/09/30 | 1,629 | 1,634 | 1,593 | 1,618 | -12 | -0.7% | 204,000 |
| 2011/09/29 | 1,607 | 1,638 | 1,599 | 1,630 | +23 | +1.4% | 159,000 |
| 2011/09/28 | 1,589 | 1,621 | 1,589 | 1,607 | +22 | +1.4% | 164,000 |
| 2011/09/27 | 1,576 | 1,593 | 1,571 | 1,585 | +17 | +1.1% | 142,000 |
| 2011/09/26 | 1,545 | 1,595 | 1,545 | 1,568 | +30 | +2% | 279,000 |
| 2011/09/22 | 1,560 | 1,560 | 1,530 | 1,538 | -21 | -1.3% | 243,000 |
| 2011/09/21 | 1,571 | 1,576 | 1,555 | 1,559 | -2 | -0.1% | 96,000 |
| 2011/09/20 | 1,571 | 1,591 | 1,556 | 1,561 | -35 | -2.2% | 200,000 |
| 2011/09/16 | 1,605 | 1,612 | 1,586 | 1,596 | -12 | -0.7% | 163,000 |
| 2011/09/15 | 1,607 | 1,619 | 1,600 | 1,608 | +1 | +0.1% | 118,000 |
| 2011/09/14 | 1,591 | 1,619 | 1,583 | 1,607 | -3 | -0.2% | 246,000 |
| 2011/09/13 | 1,593 | 1,616 | 1,584 | 1,610 | +40 | +2.5% | 297,000 |
| 2011/09/12 | 1,551 | 1,572 | 1,548 | 1,570 | +2 | +0.1% | 126,000 |
| 2011/09/09 | 1,563 | 1,585 | 1,563 | 1,568 | +11 | +0.7% | 156,000 |
| 2011/09/08 | 1,548 | 1,560 | 1,541 | 1,557 | +9 | +0.6% | 87,000 |
| 2011/09/07 | 1,544 | 1,558 | 1,544 | 1,548 | +6 | +0.4% | 162,000 |
| 2011/09/06 | 1,548 | 1,562 | 1,542 | 1,542 | -5 | -0.3% | 159,000 |
| 2011/09/05 | 1,537 | 1,556 | 1,537 | 1,547 | -8 | -0.5% | 68,000 |
| 2011/09/02 | 1,565 | 1,577 | 1,545 | 1,555 | +9 | +0.6% | 240,000 |
| 2011/09/01 | 1,561 | 1,570 | 1,536 | 1,546 | -2 | -0.1% | 160,000 |
| 2011/08/31 | 1,525 | 1,599 | 1,525 | 1,548 | +32 | +2.1% | 269,000 |
| 2011/08/30 | 1,526 | 1,537 | 1,502 | 1,516 | +2 | +0.1% | 295,000 |
| 2011/08/29 | 1,462 | 1,535 | 1,462 | 1,514 | -12 | -0.8% | 333,000 |
| 2011/08/26 | 1,523 | 1,538 | 1,519 | 1,526 | -8 | -0.5% | 117,000 |
| 2011/08/25 | 1,541 | 1,551 | 1,530 | 1,534 | -11 | -0.7% | 133,000 |
| 2011/08/24 | 1,568 | 1,568 | 1,538 | 1,545 | -28 | -1.8% | 247,000 |
| 2011/08/23 | 1,579 | 1,581 | 1,564 | 1,573 | +2 | +0.1% | 165,000 |
| 2011/08/22 | 1,569 | 1,585 | 1,558 | 1,571 | -9 | -0.6% | 174,000 |
| 2011/08/19 | 1,560 | 1,585 | 1,560 | 1,580 | -3 | -0.2% | 135,000 |
| 2011/08/18 | 1,580 | 1,596 | 1,572 | 1,583 | -3 | -0.2% | 200,000 |
| 2011/08/17 | 1,596 | 1,597 | 1,580 | 1,586 | -3 | -0.2% | 107,000 |
| 2011/08/16 | 1,602 | 1,602 | 1,575 | 1,589 | -3 | -0.2% | 77,000 |
| 2011/08/15 | 1,589 | 1,599 | 1,585 | 1,592 | +4 | +0.3% | 91,000 |
| 2011/08/12 | 1,592 | 1,593 | 1,577 | 1,588 | +12 | +0.8% | 141,000 |
3201～
3250
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.27倍 | 1.47倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ＪＣＲファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| 栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
